1.
VELCADE | Home
VELCADE was the first medicine in more than 10 years approved by the FDA for the treatment of patients with multiple myeloma. Multiple myeloma is a cancer ...
2.
VELCADE | Home
VELCADE is the only medicine the FDA has approved to treat patients with mantle cell lymphoma who have received at least 1 prior therapy. ...
3.
VELCADE | Home
VELCADE was the first medicine in more than 10 years approved by the FDA for the treatment of patients with multiple myeloma. Multiple myeloma is a cancer ...
4.
VELCADE | Home
VELCADE was the first medicine in more than 10 years approved by the FDA for the treatment of patients with multiple myeloma. Multiple myeloma is a cancer ...
5.
VELCADE
Peripheral Neuropathy: VELCADE treatment causes a peripheral neuropathy that is predominantly sensory. However, cases of severe sensory and motor peripheral ...
6.
VELCADE | Home
VELCADE was the first medicine in more than 10 years approved by the FDA for the treatment of patients with multiple myeloma. Multiple myeloma is a cancer ...
7.
Velcade | Treatment with VELCADE
Treatment with VELCADE ® for previously untreated patients. The FDA approved VELCADE to treat patients who have not yet been treated for multiple myeloma. ...
8.
VELCADE | Home
VELCADE was the first medicine in more than 10 years approved by the FDA for the treatment of patients with multiple myeloma. Multiple myeloma is a cancer ...
9.
VELCADE
VELCADE® (bortezomib) for Injection is indicated for the treatment of patients with multiple myeloma. VELCADE is contraindicated in patients with ...
10.
VELCADE | Home
VELCADE was the first medicine in more than 10 years approved by the FDA for the treatment of patients with multiple myeloma. Multiple myeloma is a cancer ...